Maki Nishimura Selected Research

beta-Galactoside alpha-2,3-Sialyltransferase

11/2013

α2-3 Sialic acid glycoconjugate loss and its effect on infection with Toxoplasma parasites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maki Nishimura Research Topics

Disease

10	Infections 01/2019 - 03/2012
2	Neoplasms (Cancer) 01/2023 - 02/2021
2	Necrosis 03/2016 - 01/2016
2	Parasitemia 01/2016 - 01/2015
1	Adenocarcinoma 01/2023
1	Ascites 01/2018
1	Toxoplasmosis 01/2017
1	Persistent Infection 02/2016

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 01/2023 - 08/2013
2	LigandsIBA 01/2023 - 02/2021
2	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 03/2016
2	Clodronic Acid (Clodronate)IBA 01/2016 - 01/2015
2	Liposomes (Liposome)IBA 01/2015 - 08/2013
1	InterferonsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Monoclonal AntibodiesIBA 02/2021
1	Toll-Like Receptor 2IBA 01/2019
1	CC ChemokinesIBA 01/2017
1	Plant Growth Regulators (Plant Hormones)IBA 08/2016
1	fluridoneIBA 08/2016
1	CytokinesIBA 03/2016
1	Sucrose (Saccharose)IBA 02/2016
1	FibrinIBA 01/2016
1	Chemokine ReceptorsIBA 01/2015
1	Sialic AcidsIBA 11/2013
1	GlycoconjugatesIBA 11/2013
1	beta-Galactoside alpha-2,3-SialyltransferaseIBA 11/2013
1	Neuraminidase (Sialidase)IBA 11/2013
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2013
1	mannotrioseIBA 08/2013
1	Immunoglobulin G (IgG)IBA 07/2012
1	AntigensIBA 03/2012
1	EnzymesIBA 03/2012
1	ImmunosorbentsIBA 03/2012

Therapy/Procedure

2	Immunotherapy 01/2023 - 02/2021
1	Therapeutics 01/2023